287 related articles for article (PubMed ID: 12747000)
1. Oral contraceptives and venous thromboembolic events.
Shulman LP; Goldzieher JW; Minkin MJ; Sulak PJ; Thorneycroft I
J Reprod Med; 2003 Apr; 48(4):306-7. PubMed ID: 12747000
[No Abstract] [Full Text] [Related]
2. The effect of different hormonal contraceptives on plasma levels of free protein S and free TFPI.
Raps M; Helmerhorst FM; Fleischer K; Dahm AE; Rosendaal FR; Rosing J; Reitsma P; Sandset PM; van Vliet HA
Thromb Haemost; 2013 Apr; 109(4):606-13. PubMed ID: 23407778
[TBL] [Abstract][Full Text] [Related]
3. What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel?
Meurer LN; Slawson JG
J Fam Pract; 2001 Feb; 50(2):108. PubMed ID: 11219554
[No Abstract] [Full Text] [Related]
4. Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis.
Stegeman BH; de Bastos M; Rosendaal FR; van Hylckama Vlieg A; Helmerhorst FM; Stijnen T; Dekkers OM
BMJ; 2013 Sep; 347():f5298. PubMed ID: 24030561
[TBL] [Abstract][Full Text] [Related]
5. Combined hormonal contraception and the risk of venous thromboembolism: a guideline.
;
Fertil Steril; 2017 Jan; 107(1):43-51. PubMed ID: 27793376
[TBL] [Abstract][Full Text] [Related]
6. [Peroral hormonal contraception and risk of venous thromboembolism].
Ludka O; Spinar J; Musil V; Pozdísek Z
Vnitr Lek; 2010 May; 56(5):370-5. PubMed ID: 20578585
[TBL] [Abstract][Full Text] [Related]
7. Risk of venous thrombosis varies with different types of combined oral contraceptives.
DeSancho MT
Evid Based Med; 2014 Apr; 19(2):e11. PubMed ID: 24288174
[No Abstract] [Full Text] [Related]
8. Do third-generation oral contraceptives (OCs) increase the risk of venous thrombosis?
Sapp AV; Lindbloom EJ
J Fam Pract; 2001 Oct; 50(10):893. PubMed ID: 11674894
[No Abstract] [Full Text] [Related]
9. ACP Journal Club. Review: Combined oral contraceptives are associated with venous thrombosis.
Harper DM; Wilfling LE; Blanner CF
Ann Intern Med; 2013 Dec; 159(12):JC12. PubMed ID: 24343405
[No Abstract] [Full Text] [Related]
10. Incidence of venous thromboembolism in users of combined oral contraceptives. Methods for identifying cases and estimating person time at risk must be detailed.
Jick H
BMJ; 2000 Jan; 320(7226):57; author reply 57-8. PubMed ID: 10617543
[No Abstract] [Full Text] [Related]
11. Instrumental variable analysis as a complementary analysis in studies of adverse effects: venous thromboembolism and second-generation versus third-generation oral contraceptives.
Boef AG; Souverein PC; Vandenbroucke JP; van Hylckama Vlieg A; de Boer A; le Cessie S; Dekkers OM
Pharmacoepidemiol Drug Saf; 2016 Mar; 25(3):317-24. PubMed ID: 26749045
[TBL] [Abstract][Full Text] [Related]
12. [Hormonal contraception and risk of venous thromboembolism: When to ask for an assessment of hemostasis? Which parameters?].
Plu-Bureau G; Horellou MH; Gompel A; Conard J
Gynecol Obstet Fertil; 2008 Apr; 36(4):448-54. PubMed ID: 18424163
[TBL] [Abstract][Full Text] [Related]
13. [Lowering the steroid dose in oral contraception and risk of functional ovarian cysts].
Mayenga JM; Segard L; Cohen J; Belaïsch-Allart J
Contracept Fertil Sex; 1995; 23(7-8):439-41. PubMed ID: 7550556
[No Abstract] [Full Text] [Related]
14. Incidence of venous thromboembolism in users of combined oral contraceptives. Risk is particularly high with first use of oral contraceptives.
Vandenbrouke JP; Bloemenkamp KW; Rosendaal FR; Helmerhorst FM
BMJ; 2000 Jan; 320(7226):57-8. PubMed ID: 10671043
[No Abstract] [Full Text] [Related]
15. Renewed interest in haemostasis changes induced by oral contraceptives (OCs).
Kluft C
Thromb Haemost; 2000 Jul; 84(1):1-3. PubMed ID: 10928460
[No Abstract] [Full Text] [Related]
16. [Vascular thrombosis and oral contraceptives].
Lefèvre D; Mouroziès X; Fontan R; Hammoudi S; Becade P; Mazères F; Bastide G
Phlebologie; 1987; 40(4):981-6. PubMed ID: 3447202
[TBL] [Abstract][Full Text] [Related]
17. [How to choose a contraceptive pill that suits?].
Kivijärvi A
Duodecim; 1997; 113(12):1169-73. PubMed ID: 11466847
[No Abstract] [Full Text] [Related]
18. Effect of ethinylestradiol dose and progestagen in combined oral contraceptives on plasma sex hormone-binding globulin levels in premenopausal women.
Stegeman BH; Raps M; Helmerhorst FM; Vos HL; van Vliet HA; Rosendaal FR; van Hylckama Vlieg A
J Thromb Haemost; 2013 Jan; 11(1):203-5. PubMed ID: 23122048
[No Abstract] [Full Text] [Related]
19. Contraceptive for obese women: considerations.
Kelsey B
Nurse Pract; 2010 Mar; 35(3):24-31; quiz 31-2. PubMed ID: 20164732
[No Abstract] [Full Text] [Related]
20. [Benefits and risk of the modern combined hormonal contraception].
Fait T; Nouzová K; Sýkorová P; Fanta M; Vrablík M; Skrenková J
Cas Lek Cesk; 2005; 144(4):238-44. PubMed ID: 15945482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
